Analyst downgraded Lineage from Overweight to Neutral and set a new price target of $75.00 from $78.00 previously
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/12/2025 | $42.00 | Neutral → Underperform | BNP Paribas Exane |
5/6/2025 | $49.00 | Buy → Neutral | BofA Securities |
4/10/2025 | $56.00 | Sector Outperform → Sector Perform | Scotiabank |
3/28/2025 | $64.00 | Neutral | Citigroup |
1/14/2025 | $61.00 | Neutral | Exane BNP Paribas |
12/20/2024 | $78.00 → $75.00 | Overweight → Neutral | Analyst |
9/18/2024 | $91.00 | Overweight | CapitalOne |
9/16/2024 | $91.00 | Overweight | CapitalOne |
8-K - Lineage, Inc. (0001868159) (Filer)
8-K - Lineage, Inc. (0001868159) (Filer)
8-K - Lineage, Inc. (0001868159) (Filer)
4 - Lineage, Inc. (0001868159) (Issuer)
4 - Lineage, Inc. (0001868159) (Issuer)
4 - Lineage, Inc. (0001868159) (Issuer)
4 - Lineage, Inc. (0001868159) (Issuer)
4 - Lineage, Inc. (0001868159) (Issuer)
4 - Lineage, Inc. (0001868159) (Issuer)